Amicus Therapeutics, Inc.FOLDNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank93
3Y CAGR+110.4%
5Y CAGR+18.3%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+110.4%/yr
Annual compound
5Y CAGR
+18.3%/yr
Recent acceleration
Percentile
P93
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 51.68% |
| 2024 | 62.99% |
| 2023 | 35.92% |
| 2022 | 5.55% |
| 2021 | 9.53% |
| 2020 | 22.32% |
| 2019 | -2.12% |
| 2018 | -22.88% |
| 2017 | -41.97% |
| 2016 | -51.41% |